| Kwame O Akosah, MD | |
|
501 Sunset Ln, 1st Floor, Room 1108, Culpeper, VA 22701-3917 | |
| (540) 829-4400 | |
| (540) 829-5001 |
| Full Name | Kwame O Akosah |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Cardiovascular Disease |
| Location | 501 Sunset Ln, Culpeper, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710989074 | NPI | - | NPPES |
| 0074732 | Medicaid | OH | |
| 3810006639 | Medicaid | WV | |
| 1026617800001 | Medicaid | PA | |
| 32394700 | Medicaid | WI |
| Entity Name | University Of Virginia Physicians Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033138250 PECOS PAC ID: 4880590728 Enrollment ID: O20040102000780 |
News Archive
An extended analysis of cancer rates reinforces a strong association between use of hormone replacement therapy (HRT) and increased breast cancer incidence, according to research led by scientists at The University of Texas M. D. Anderson Cancer Center and published in the New England Journal of Medicine.
Medivir AB today announced it has appointed Daewoong Pharmaceutical Co. Ltd. as its exclusive distributor for Xerclear™ in South Korea. Under the terms of the agreement, Daewoong will be responsible for obtaining the regulatory approvals, and for marketing, sales and distribution of Medivir's cold sore product in the territory. In consideration of the rights granted to Daewoong, Medivir will receive upfront and milestone payments and royalties on sales according to a profit sharing scheme.
Endo Pharmaceuticals announced that it has licensed from Grunenthal the exclusive rights to develop and market the investigational drug axomadol in the United States and Canada.
On September 30, the U.S. Senate voted to adopt a measure aimed at rewarding healthy behavior as part of the Obama Administration's overall healthcare reform legislation. The Senate Finance Committee voted for a bi-partisan amendment that would allow health plans to provide financial incentives for people to quit smoking, exercise more and engage in other healthy activities.
Crown Bioscience, Inc., a leading global drug discovery and development service company, has announced its first European symposium, detailing the use of Translational Platforms including Patient-Derived Xenograft (PDX) models in oncology drug discovery and development. The conference will be held on Wednesday 11th February, at the headquarters of One Nucleus in Cambridge, UK and will welcome experts from renowned pharmaceutical companies and prominent academics working in oncology.
› Verified 5 days ago
| Entity Name | Uva Culpeper Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669538047 PECOS PAC ID: 5698671170 Enrollment ID: O20050505000522 |
News Archive
An extended analysis of cancer rates reinforces a strong association between use of hormone replacement therapy (HRT) and increased breast cancer incidence, according to research led by scientists at The University of Texas M. D. Anderson Cancer Center and published in the New England Journal of Medicine.
Medivir AB today announced it has appointed Daewoong Pharmaceutical Co. Ltd. as its exclusive distributor for Xerclear™ in South Korea. Under the terms of the agreement, Daewoong will be responsible for obtaining the regulatory approvals, and for marketing, sales and distribution of Medivir's cold sore product in the territory. In consideration of the rights granted to Daewoong, Medivir will receive upfront and milestone payments and royalties on sales according to a profit sharing scheme.
Endo Pharmaceuticals announced that it has licensed from Grunenthal the exclusive rights to develop and market the investigational drug axomadol in the United States and Canada.
On September 30, the U.S. Senate voted to adopt a measure aimed at rewarding healthy behavior as part of the Obama Administration's overall healthcare reform legislation. The Senate Finance Committee voted for a bi-partisan amendment that would allow health plans to provide financial incentives for people to quit smoking, exercise more and engage in other healthy activities.
Crown Bioscience, Inc., a leading global drug discovery and development service company, has announced its first European symposium, detailing the use of Translational Platforms including Patient-Derived Xenograft (PDX) models in oncology drug discovery and development. The conference will be held on Wednesday 11th February, at the headquarters of One Nucleus in Cambridge, UK and will welcome experts from renowned pharmaceutical companies and prominent academics working in oncology.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kwame O Akosah, MD Po Box 9007, Charlottesville, VA 22906-9007 Ph: () - | Kwame O Akosah, MD 501 Sunset Ln, 1st Floor, Room 1108, Culpeper, VA 22701-3917 Ph: (540) 829-4400 |
News Archive
An extended analysis of cancer rates reinforces a strong association between use of hormone replacement therapy (HRT) and increased breast cancer incidence, according to research led by scientists at The University of Texas M. D. Anderson Cancer Center and published in the New England Journal of Medicine.
Medivir AB today announced it has appointed Daewoong Pharmaceutical Co. Ltd. as its exclusive distributor for Xerclear™ in South Korea. Under the terms of the agreement, Daewoong will be responsible for obtaining the regulatory approvals, and for marketing, sales and distribution of Medivir's cold sore product in the territory. In consideration of the rights granted to Daewoong, Medivir will receive upfront and milestone payments and royalties on sales according to a profit sharing scheme.
Endo Pharmaceuticals announced that it has licensed from Grunenthal the exclusive rights to develop and market the investigational drug axomadol in the United States and Canada.
On September 30, the U.S. Senate voted to adopt a measure aimed at rewarding healthy behavior as part of the Obama Administration's overall healthcare reform legislation. The Senate Finance Committee voted for a bi-partisan amendment that would allow health plans to provide financial incentives for people to quit smoking, exercise more and engage in other healthy activities.
Crown Bioscience, Inc., a leading global drug discovery and development service company, has announced its first European symposium, detailing the use of Translational Platforms including Patient-Derived Xenograft (PDX) models in oncology drug discovery and development. The conference will be held on Wednesday 11th February, at the headquarters of One Nucleus in Cambridge, UK and will welcome experts from renowned pharmaceutical companies and prominent academics working in oncology.
› Verified 5 days ago
Dr. Sagar Verma, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 501 Sunset Ln, Culpeper, VA 22701 Phone: 703-396-5292 Fax: 703-396-5297 | |
Joshua D. King, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 501 Sunset Ln, Culpeper, VA 22701 Phone: 540-829-4100 | |
Parminder Kaur, Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 501 Sunset Ln, Culpeper, VA 22701 Phone: 540-829-4100 | |
Marta Inga Lafata, N.P. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 501 Sunset Ln, Culpeper, VA 22701 Phone: 540-829-4100 Fax: 610-834-2862 | |
Shubhada Kumar, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 501 Sunset Ln, Culpeper, VA 22701 Phone: 703-396-5292 Fax: 703-396-5297 | |
Dr. Andrew J Keller, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 501 Sunset Ln, Culpeper, VA 22701 Phone: 540-829-4100 Fax: 540-829-5001 | |
Kwadwo O Boadi, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 501 Sunset Lane, Culpeper, VA 22701 Phone: 540-829-4100 |